Viropharma, Inc. (NQ: VPHM)
49.96 USD  UNCHANGED
Last Price  /  Updated: 8:10 PM EST, Jan 24, 2014  /  Add to My Watchlist      
(VPHM) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 19, 2014
(Stock Blog Hub, 4/27/13)
ViroPharma Incorporated (VPHM) recently announced results from a phase II study of its candidate VP20621 (non-toxigenic Clostridium difficile), which is being developed to...(read more)
(Stock Blog Hub, 8/9/12)
The US Food and Drug Administration (FDA) recently approved ViroPharma Incorporated’s (VPHM) supplement to the Cinryze Biologics License Application (BLA)...(read more)
(Penny Stock DD, 2/28/11)
Sangamo Biosciences, Inc. (NASDAQ:SGMO) surged by 12.29% and closed at $8.50 whereas overall traded volume stood at 1.47 million shares for the day as compare to its...(read more)
ViroPharma (VPHM) Company Overview

There is no analysis for VPHM yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here